Truist Securities maintains Gilead Sciences (NASDAQ:GILD) $91 price target

By / / Gilead Sciences, Truist Financial

Truist Securities analyst Robyn Karnauskas reiterates Gilead Sciences (NASDAQ:GILD) with a Buy and maintains $91 price target.

Scroll to Top